News
-
Aclarion Announces First Commercial Agreement with Scripps Health
March 3, 2025 -
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
February 28, 2025 -
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
February 20, 2025 -
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
February 11, 2025 -
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
February 6, 2025 -
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
February 4, 2025 -
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
January 31, 2025 -
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
January 30, 2025 -
Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split
January 28, 2025 -
Aclarion Announces Reverse Stock Split
January 24, 2025